Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Clinical Utility of Mindfulness Training in the Treatment of Fatigue After Stroke, Traumatic Brain Injury and Multiple Sclerosis: A Systematic Literature Review and Meta-analysis.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Aquaporin modulators: a patent review (2010-2015).
The Gas6/TAM System and Multiple Sclerosis.
Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study.
Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines.
Field inhomogeneity correction for gradient echo myelin water fraction imaging.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
Special Issue: Myelin Repair.
The Sphingosine-1-phosphate Analogue, FTY -720, Promotes the Proliferation of Embryonic Neural Stem Cells, Enhances Hippocampal Neurogenesis and Learning and Memory Abilities in Adult Mice.
Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model.
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.
Clinical Profile of Patients Requiring Prolonged Mechanical Ventilation and their Outcome in a Tertiary Care Medical ICU.
Limbic Pathway Correlates of Cognitive Impairment in Multiple Sclerosis.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature.
DNA damage in the oligodendrocyte lineage and its role in brain aging.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
Social isolation impairs remyelination in mice through modulation of IL-6.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.
Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features.
Pages
« first
‹ previous
…
792
793
794
795
796
797
798
799
800
…
next ›
last »